Skip to main content

What Scientists Know About the B.1.617 Coronavirus Variant

While some experts speculate the variant could be partially responsible for India’s current surge in SARS-CoV-2 infections, information about the effects of its mutations is only beginning to emerge.

Written byShawna Williams
| 2 min read
coronavirus particles in a variety of colors with a world map in background

Register for free to listen to this article
Listen with Speechify
0:00
2:00

ABOVE: © ISTOCK.COM, WILDPIXEL

Update (May 11): CNBC reports that the World Health Organization now considers B.1.617 a variant of concern, following an analysis by one of its working groups that indicated the variant is more transmissible than the original one.

With India in the grip of a devastating second wave of COVID-19—the country recorded more than 368,000 new cases and 3,417 deaths from the disease yesterday—some have suggested that a variant first detected there in October could share some of the blame. The B.1.617 version of the coronavirus carries the ominous nickname “double mutant,” but it has more than two sequence changes from older SARS-CoV-2 variants, and little is known so far about the effects of these alterations, if any, on disease severity or the virus’s ability to evade immunity gained through infection or vaccines.

One preliminary bit of insight emerged on April 23, when researchers reported in a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Qiagen Logo
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays